Natixis Advisors’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-148,096
Closed -$2.9M 1508
2022
Q2
$2.9M Sell
148,096
-37,357
-20% -$783K 0.01% 801
2022
Q1
$4.02M Buy
185,453
+8,390
+5% +$178K 0.02% 753
2021
Q4
$4.17M Buy
177,063
+14,683
+9% +$351K 0.02% 729
2021
Q3
$4.25M Buy
162,380
+18,728
+13% +$453K 0.02% 696
2021
Q2
$3.48M Buy
+143,652
New +$3.53M 0.02% 738

Other funds holding SHC

Natixis Advisors's SHC Position: Q3 2022 in Review

Natixis Advisors sold out of Sotera Health (SHC) in Q3 2022, closing a stake of 148,096 shares — an estimated $2.9M sold.

Natixis Advisors first reported a position in SHC in Q2 2021 and held it in 5 quarters. The position peaked at $4.25M in Q3 2021. 184 funds tracked by Wall St. Rank hold SHC as of Q3 2022.

  • Natixis Advisors reported no remaining Sotera Health position as of Q3 2022 after selling out during the quarter.
  • Natixis Advisors sold 148,096 Sotera Health shares in Q3 2022, an estimated $2.9M.
  • Natixis Advisors first reported a position in Sotera Health in Q2 2021 and held it in 5 quarters.
  • Natixis Advisors's Sotera Health position peaked at $4.25M in Q3 2021.
  • 184 funds tracked by Wall St. Rank held Sotera Health as of Q3 2022.

Based on Natixis Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.